Cancer-Fighting virus injected directly into tumors in new melanoma trial
NCT ID NCT07086105
Summary
This early-stage study is testing a modified virus called Adze1.C that's designed to infect and destroy cancer cells while potentially boosting the immune system. The virus is injected directly into tumors of adults with advanced melanoma that hasn't responded to standard treatments. Researchers will test three different dose levels to find the highest safe amount and monitor patients closely for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Monash Health
NOT_YET_RECRUITINGClayton, Victoria, 3168, Australia
Contact
-
Tasman Oncology Research
RECRUITINGSouthport, Queensland, 4215, Australia
Contact
-
The Queen Elizabeth Hospital
NOT_YET_RECRUITINGAdelaide, South Australia, 5011, Australia
Contact
Conditions
Explore the condition pages connected to this study.